BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Azadirachta indica {Neem} - Staphylococcus |
👪
Antibacterial and Antiproliferative Activities of Azadirachta indica Leaf Extract and Its Effect on Oil-in-Water Food Emulsion Stability. Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 22 Pages: Pub: 2022 Nov 11 Epub: 2022 Nov 11 Authors Ouerfelli M , Metón I , Codina-Torrella I , Almajano MP , Html Article Publication |
| Azadirachta indica {Neem} - Staphylococcus |
👪
Investigation on the biofilm eradication potential of selected medicinal plants against methicillin-resistant Staphylococcus aureus. Biotechnology reports (Amsterdam, Netherlands) (Biotechnol Rep (Amst) ) Vol: 28 Issue Pages: e00523 Pub: 2020 Dec Epub: 2020 Sep 17 Authors S LP , A U , S J GF , Html Article Publication |
| Azadirachta indica {Neem} - Staphylococcus |
👪
In vitro antibacterial activity of medicinal plants against biofilm-forming methicillin-resistant Staphylococcus aureus: efficacy of Moringa stenopetala and Rosmarinus officinalis extracts. Heliyon (Heliyon ) Vol: 6 Issue 1 Pages: e03303 Pub: 2020 Jan Epub: 2020 Jan 27 Authors Manilal A , Sabu KR , Shewangizaw M , Aklilu A , Seid M , Merdikios B , Tsegaye B , Html Article Publication |
| Azadirachta indica {Neem} - Staphylococcus |
📓
The antimicrobial activity of Azadirachta indica, Mimusops elengi, Tinospora cardifolia, Ocimum sanctum and 2% chlorhexidine gluconate on common endodontic pathogens: An in vitro study. European journal of dentistry (Eur J Dent ) Vol: 8 Issue 2 Pages: 172-177 Pub: 2014 Apr Epub: Authors Mistry KS , Sanghvi Z , Parmar G , Shah S , Html Article Publication |
| Azadirachta indica {Neem} - Staphylococcus |
👪
Microencapsulation of Azadirachta indica oil and Tinospora cordifolia extracts blend for single-use applications. Heliyon (Heliyon ) Vol: 10 Issue 20 Pages: e39163 Pub: 2024 Oct 30 Epub: 2024 Oct 9 Authors Khan O , Chandra Das S , Bedoura S , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
